光控杏仁核mGlu4受体动态调节炎性疼痛相关情感与感觉症状
该研究在动物模型中探讨杏仁核4型代谢型谷氨酸受体(mGlu4)对持续性疼痛的感觉与情感症状的调控作用。研究发现激活杏仁核mGlu4可消除痛觉过敏、焦虑抑郁样行为及恐惧消退受损,并开发了光开关正向变构调节剂optogluram,实现自由活动动物中光控动态、可逆地抑制疼痛相关行为症状。
要点
- 激活杏仁核mGlu4可消除持续性疼痛的感觉与情感症状。
- mGlu4效应经外侧杏仁核 principal 神经元及背内侧间质细胞的多感觉丘脑输入实现。
- optogluram实现自由活动动物中光控、快速可逆抑制疼痛相关行为。
核心结论
- 杏仁核mGlu4信号可绕过中枢敏化过程,动态调节持续性疼痛症状。
研究设计与样本
- 研究在动物模型中采用神经解剖与突触分析、光药理学方法,开发可扩散光开关正向变构调节剂optogluram。
主要发现
- 激活杏仁核mGlu4可消除持续性疼痛的痛觉过敏、焦虑与抑郁相关行为及恐惧消退受损。
- mGlu4激活效应发生于中央核之外,经调节多感觉丘脑输入至外侧杏仁核主神经元和背内侧间质细胞实现。
- optogluram在自由活动动物杏仁核中经光学控制快速、可逆抑制持续性疼痛相关行为症状。
临床怎么用
- 提示杏仁核mGlu4信号可作为慢性疼痛更精确治疗干预的潜在靶点。
- optogluram exemplify 光药理学在体内研究内源性神经调控机制动态活动的潜力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Contrary to acute pain, chronic pain does not serve as a warning signal and must be considered as a disease per se. This pathology presents a sensory and psychological dimension at the origin of affective and cognitive disorders. Being largely refractory to current pharmacotherapies, identification of endogenous systems involved in persistent and chronic pain is crucial. The amygdala is a key brain region linking pain sensation with negative emotions. Here, we show that activation of a specific intrinsic neuromodulatory system within the amygdala associated with type 4 metabotropic glutamate receptors (mGlu4) abolishes sensory and affective symptoms of persistent pain such as hypersensitivity to pain, anxiety- and depression-related behaviors, and fear extinction impairment. Interestingly, neuroanatomical and synaptic analysis of the amygdala circuitry suggests that the effects of mGlu4 activation occur outside the central nucleus via modulation of multisensory thalamic inputs to lateral amygdala principal neurons and dorso-medial intercalated cells. Furthermore, we developed optogluram, a small diffusible photoswitchable positive allosteric modulator of mGlu4. This ligand allows the control of endogenous mGlu4 activity with light. Using this photopharmacological approach, we rapidly and reversibly inhibited behavioral symptoms associated with persistent pain through optical control of optogluram in the amygdala of freely behaving animals. Altogether, our data identify amygdala mGlu4 signaling as a mechanism that bypasses central sensitization processes to dynamically modulate persistent pain symptoms. Our findings help to define novel and more precise therapeutic interventions for chronic pain, and exemplify the potential of optopharmacology to study the dynamic activity of endogenous neuromodulatory mechanisms in vivo.
引用
- Zussy C, Gómez-Santacana X, Rovira X, et al. Dynamic modulation of inflammatory pain-related affective and sensory symptoms by optical control of amygdala metabotropic glutamate receptor 4. Mol Psychiatry. 2016. PMID: 27994221. doi:10.1038/mp.2016.223
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。